Pyxis Oncology Inc (PYXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1993 | 03-1993 | 12-1992 | 09-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 396 | 4,669 | 2,468 | 905 | 295 |
| TOTAL | $396 | $4,669 | $2,468 | $905 | $295 |
| Non-Current Assets | |||||
| Investments And Advances | 25,739 | 33,264 | 10,049 | 1,506 | 0 |
| Other Non-Current Assets | 173 | 190 | 8,660 | 3,155 | 2,913 |
| TOTAL | $25,912 | $33,454 | $18,709 | $4,661 | $2,913 |
| Total Assets | $26,308 | $38,123 | $21,177 | $5,566 | $3,208 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 918 | 944 | 1,037 | 914 | 491 |
| Accounts payable and accrued liabilities | 2,221 | 2,575 | 1,538 | 1,304 | 502 |
| Accrued Expenses | 4,113 | 3,412 | 2,547 | 2,220 | 263 |
| TOTAL | $7,252 | $6,931 | $5,121 | $4,438 | $1,256 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,085 | 0 | 866 | 779 | 224 |
| TOTAL | $11,132 | $7,281 | $5,766 | $2,069 | $224 |
| Total Liabilities | $18,384 | $14,212 | $10,887 | $6,507 | $1,480 |
| Shareholders' Equity | |||||
| Common Shares | 174 | 173 | 172 | 172 | 11 |
| TOTAL | $83,607 | $83,143 | $83,101 | $82,845 | $23,794 |
| Total Liabilities And Equity | $101,991 | $97,355 | $93,988 | $89,351 | $25,274 |